Quercetin reverses experimental cirrhosis by immunomodulation of the proinflammatory and profibrotic processes.

MLA

Casas-Grajales, Sael, et al. “Quercetin Reverses Experimental Cirrhosis by Immunomodulation of the Proinflammatory and Profibrotic Processes.” Fundamental & Clinical Pharmacology, vol. 31, no. 6, Dec. 2017, pp. 610–24. EBSCOhost, https://doi.org/10.1111/fcp.12315.

APA

Casas-Grajales, S., Vázquez-Flores, L. F., Ramos-Tovar, E., Hernández-Aquino, E., Flores-Beltrán, R. E., Cerda-García-Rojas, C. M., Camacho, J., Shibayama, M., Tsutsumi, V., & Muriel, P. (2017). Quercetin reverses experimental cirrhosis by immunomodulation of the proinflammatory and profibrotic processes. Fundamental & Clinical Pharmacology, 31(6), 610–624. https://doi.org/10.1111/fcp.12315

Chicago

Casas-Grajales, Sael, Luis F Vázquez-Flores, Erika Ramos-Tovar, Erika Hernández-Aquino, Rosa E Flores-Beltrán, Carlos M Cerda-García-Rojas, Javier Camacho, Mineko Shibayama, Víctor Tsutsumi, and Pablo Muriel. 2017. “Quercetin Reverses Experimental Cirrhosis by Immunomodulation of the Proinflammatory and Profibrotic Processes.” Fundamental & Clinical Pharmacology 31 (6): 610–24. doi:10.1111/fcp.12315.